Clough Capital Partners L P Equillium, Inc. Transaction History

Clough Capital Partners L P

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$3.31 - $5.6 $1.03 Million - $1.75 Million	-312,300 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.84 - $12.02 $217,832 - $448,346	37,300 Added 13.56%	312,300 $2.5 Million
Q4 2018 Feb 14, 2019	BUY	$6.32 - $19.44 $1.74 Million - $5.35 Million	275,000 New	275,000 $2.24 Million

11.5M

38.1K

Ticker EQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,352,100
Market Cap $47.1M
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

Stay updated on Clough Capital Partners L P with notifications on news.